Cefaclor (Lilly 99638) and cefatrizine (BL-S640, SK&F 70771) are orally absorbed, broad-spectrum semisynthetic cephalosporins. They were compared in vitro with cephalexin, cephaloglycin, and cepharadine against a variety of aerobic pathogenic bacteria by an agar dilution procedure. Cefaclor and cefatrizine were found to be similar or superior to cephalexin, cephaloglycin, and cephradine in terms of activity against gram-positive cocci other than enterococci. Only cefatrizine demonstrated any potentially useful activity against some susceptible isolates of enterococci. Cefaclor and cefatrizine also were highly active, equally or more so than the other oral cephalosporins, against several gram-negative species including Escherichia coli, Enterobacter aerogenes, and Klebsiella pneumoniae. None of the cephalosporins were particularly active against Enterobacter cloacae. Both cefaclor and cefatrizine were active against Proteus mirabilis; cefatrizine was uniquely active against indolepositive Proteus species.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC429985PMC
http://dx.doi.org/10.1128/AAC.12.5.609DOI Listing

Publication Analysis

Top Keywords

cefaclor cefatrizine
12
oral cephalosporins
8
aerobic pathogenic
8
pathogenic bacteria
8
cephalexin cephaloglycin
8
cefatrizine
6
vitro activities
4
activities oral
4
cephalosporins
4
cephalosporins aerobic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!